Casper de Clercq, MS, MBA
Norwest Venture Partners, Palo Alto, California

With over 30 years of experience, Casper is a veteran of the medical device and life sciences industry, having led marketing and commercialization efforts for companies that span the healthcare space. He brings extensive operating knowledge to Norwest Venture Partners, where he focuses on mid-to-late-stage investments in consumer and digital health, healthcare IT, medical devices and diagnostics, technology-enabled healthcare services, and specialty pharmaceuticals. He currently serves on the boards of iRhythm Technologies (Nasdaq: IRTC), Telcare, Crossover Health, Omada Health, and NextHealth Technologies. Casper was previously on the board of Basis (acquired by Intel) and Intersect ENT (Nasdaq: XENT). Casper is also responsible for Norwest’s investment in Misfit Wearables (acquired by Fossil).